Aronne M. Schottstaedt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aronne M. Schottstaedt has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Adam Currey
Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin
21 shared publications - Alexis Vistocky
Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin
21 shared publications - Anjishnu Banerjee
Department of Biostatistics, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA
21 shared publications - Carmen Bergom
Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
21 shared publications - Christopher R. Chitambar
Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Department of Biophysics, Medical College of Wisconsin, Milwaukee, Wisconsin
21 shared publications - Gopika SenthilKumar
Medical Scientist Training Program, Medical College of Wisconsin, Milwaukee, Wisconsin
21 shared publications
Latest Publications
- Open Access
- 7 May 2024
- Published by American Association for Cancer Research (AACR)
TABLE 5 from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
Comparisons of cytokine levels at baseline, 3 months, and 6 months
- 7 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTABLE 5 from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
Comparisons of cytokine levels at baseline, 3 months, and 6 months
- Open Access
- 7 May 2024
- Published by American Association for Cancer Research (AACR)
TABLE 5 from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
Comparisons of cytokine levels at baseline, 3 months, and 6 months
- 7 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTABLE 5 from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
Comparisons of cytokine levels at baseline, 3 months, and 6 months
- Open Access
- 7 May 2024
- Published by American Association for Cancer Research (AACR)
TABLE 4 from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
Comparisons of resting metabolism and energy expenditure, and metabolic biomarkers at baseline, 3 months, and 6 months
- 7 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTABLE 4 from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
Comparisons of resting metabolism and energy expenditure, and metabolic biomarkers at baseline, 3 months, and 6 months
- Open Access
- 7 May 2024
- Published by American Association for Cancer Research (AACR)
TABLE 4 from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
Comparisons of resting metabolism and energy expenditure, and metabolic biomarkers at baseline, 3 months, and 6 months
- 7 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTABLE 4 from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
Comparisons of resting metabolism and energy expenditure, and metabolic biomarkers at baseline, 3 months, and 6 months
- Open Access
- 7 May 2024
- Published by American Association for Cancer Research (AACR)
Data from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
Purpose:Among patients with breast cancer undergoing radiotherapy, posttreatment cardiovascular disease and worsened quality of life (QoL) are leading causes of morbidity and mortality. To overcome these negative radiotherapy effects, this prospective, randomized clinical trial pilots a 12-week Stay on Track exercise and diet intervention for overweight patients with nonmetastatic breast cancer undergoing whole-breast radiotherapy.Experimental Design:The intervention group (n = 22) participated in three personal exercise and dietary counseling sessions, and received three text reminders/week to adhere to recommendations. The control group (n = 22) was administered a diet/exercise information binder. All patients received a Fitbit, and at baseline, 3 months, and 6 months, measurements of biomarkers, dual-energy X-ray absorptiometry scans, QoL and physical activity surveys, and food frequency questionnaires were obtained. A satisfaction survey was administered at 3 months.Results:Stay on Track was well received, with high rates of adherence and satisfaction. The intervention group showed an increase in self-reported physical activity and preserved QoL, a decrease in body mass index and visceral fat, and higher American Cancer Society/American Institute of Cancer Research dietary adherence. The control participants had reduced QoL, anti-inflammatory markers, and increased metabolic syndrome markers. Both groups had decreased overall body mass. These changes were within group effects. When comparing the intervention and control groups over time, there were notable improvements in dietary adherence in the intervention group.Conclusions:Targeted lifestyle interventions during radiotherapy are feasible and could decrease cardiovascular comorbidities in patients with breast cancer. Larger-scale implementation with longer follow-up can better determine interventions that influence cardiometabolic health and QoL.Significance:This pilot study examines cardiometabolic benefits of a combined diet and exercise intervention for patients with breast cancer undergoing radiotherapy. The intervention included an activity tracker (FitBit) and text message reminders to promote adherence to lifestyle interventions. Large-scale implementation of such programs may improve cardiometabolic outcomes and overall QoL among patients with breast cancer.
- 7 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
Purpose:Among patients with breast cancer undergoing radiotherapy, posttreatment cardiovascular disease and worsened quality of life (QoL) are leading causes of morbidity and mortality. To overcome these negative radiotherapy effects, this prospective, randomized clinical trial pilots a 12-week Stay on Track exercise and diet intervention for overweight patients with nonmetastatic breast cancer undergoing whole-breast radiotherapy.Experimental Design:The intervention group (n = 22) participated in three personal exercise and dietary counseling sessions, and received three text reminders/week to adhere to recommendations. The control group (n = 22) was administered a diet/exercise information binder. All patients received a Fitbit, and at baseline, 3 months, and 6 months, measurements of biomarkers, dual-energy X-ray absorptiometry scans, QoL and physical activity surveys, and food frequency questionnaires were obtained. A satisfaction survey was administered at 3 months.Results:Stay on Track was well received, with high rates of adherence and satisfaction. The intervention group showed an increase in self-reported physical activity and preserved QoL, a decrease in body mass index and visceral fat, and higher American Cancer Society/American Institute of Cancer Research dietary adherence. The control participants had reduced QoL, anti-inflammatory markers, and increased metabolic syndrome markers. Both groups had decreased overall body mass. These changes were within group effects. When comparing the intervention and control groups over time, there were notable improvements in dietary adherence in the intervention group.Conclusions:Targeted lifestyle interventions during radiotherapy are feasible and could decrease cardiovascular comorbidities in patients with breast cancer. Larger-scale implementation with longer follow-up can better determine interventions that influence cardiometabolic health and QoL.Significance:This pilot study examines cardiometabolic benefits of a combined diet and exercise intervention for patients with breast cancer undergoing radiotherapy. The intervention included an activity tracker (FitBit) and text message reminders to promote adherence to lifestyle interventions. Large-scale implementation of such programs may improve cardiometabolic outcomes and overall QoL among patients with breast cancer.
- Open Access
- 7 May 2024
- Published by American Association for Cancer Research (AACR)
TABLE 2 from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
QoL measures and patient-reported physical activity at baseline, 3 months, and 6 months
- 7 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTABLE 2 from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
QoL measures and patient-reported physical activity at baseline, 3 months, and 6 months
- Open Access
- 7 May 2024
- Published by American Association for Cancer Research (AACR)
TABLE 3 from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
Body composition and DEXA scan analysis at baseline, 3 months, and 6 months
- 7 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTABLE 3 from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
Body composition and DEXA scan analysis at baseline, 3 months, and 6 months
- Open Access
- 7 May 2024
- Published by American Association for Cancer Research (AACR)
FIGURE 1 from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
FIGURE 1 from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
- 7 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFIGURE 1 from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
FIGURE 1 from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
- Open Access
- 7 May 2024
- Published by American Association for Cancer Research (AACR)
TABLE 2 from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
QoL measures and patient-reported physical activity at baseline, 3 months, and 6 months
- 7 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTABLE 2 from Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy
QoL measures and patient-reported physical activity at baseline, 3 months, and 6 months